• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

    59.59 +0.16 (+0.26%)
    Streaming Delayed Price Updated: 12:08 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 390,611
    Open 59.43
    Bid (Size) 59.56 (200)
    Ask (Size) 59.61 (400)
    Prev. Close 59.43
    Today's Range 58.89 - 59.82
    52wk Range 50.76 - 73.51
    Shares Outstanding 183,352,255
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a 'Decent Value' Candidate ↗
    Via Chartmill
    News headline image
    Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
    The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme... 
    Via MarketMinute
    Topics ETFs Intellectual Property

    Performance

    YTD
    N/A
    N/A
    1 Month
    +10.6%
    +10.6%
    3 Month
    +7.2%
    +7.2%
    6 Month
    +3.6%
    +3.6%
    1 Year
    -10.4%
    -10.4%

    More News

    Read More
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal ↗
    Via Stocktwits
    News headline image
    BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know
    Via StockStory
    News headline image
    Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
    Via StockStory
    Topics Economy
    News headline image
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    News headline image
    1 Oversold Stock Primed to Rebound and 2 That Underwhelm
    Via StockStory
    News headline image
    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute
    News headline image
    2 Reasons to Like BMRN and 1 to Stay Skeptical
    Via StockStory
    Topics Stocks
    News headline image
    Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?
    Via StockStory
    Topics Stocks
    News headline image
    Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗
    Via The Motley Fool
    News headline image
    The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    1 Safe-and-Steady Stock on Our Watchlist and 2 We Question
    Via StockStory
    News headline image
    Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    3 Cash-Producing Stocks with Promising Prospects
    Via StockStory
    News headline image
    This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
    Via Benzinga
    News headline image
    BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call
    Via StockStory
    Topics Earnings

    Frequently Asked Questions

    Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
    Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
    What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
    BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
    The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
    What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
    The current price of BioMarin Pharmaceutical Inc. - Common Stock is 59.59
    When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
    The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 01/02/26 12:08 PM ET
    What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
    The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.93B
    How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
    BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.